sb 203580 has been researched along with endomorphin 1 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (endomorphin 1) | Trials (endomorphin 1) | Recent Studies (post-2010) (endomorphin 1) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 448 | 2 | 109 |
| Protein | Taxonomy | sb 203580 (IC50) | endomorphin 1 (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.026 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0275 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0363 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Fang, Q; Li, N; Qiu, Y; Xiao, J; Xu, B; Xu, K; Zhang, M; Zhang, N; Zhang, Q; Zhang, R; Zhang, T | 1 |
1 other study(ies) available for sb 203580 and endomorphin 1
| Article | Year |
|---|---|
Spinal endomorphins attenuate burn-injury pain in male mice by inhibiting p38 MAPK signaling pathway through the mu-opioid receptor.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Burns; Disease Models, Animal; Enzyme Inhibitors; Hyperalgesia; Imidazoles; Injections, Spinal; Male; Mice; Mice, Knockout; Narcotic Antagonists; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Pain; Pyridines; Receptors, Opioid, mu; Signal Transduction; Spinal Cord Injuries | 2021 |